Sort by :
![](https://www.omegahms.com/wp-content/uploads/2024/03/customer-spotlight.png)
Customer Spotlight: Omega Healthcare Celebrates Successful Collaboration with NYU Langone Health
NYU Langone Health team was recently hosted by Anurag Mehta, Co-Founder & CEO of Omega Healthcare, at our India operations. Hear directly from the team.
![](https://www.omegahms.com/wp-content/uploads/2023/05/Omega-hitrust-certified-1.jpg)
Omega Healthcare Achieves HITRUST Implemented, 1-year Certification to Manage Cybersecurity Risk and Improve Information Security Posture
HITRUST Implemented, 1-year (i1) Certification validates Omega Healthcare is operating leading security practices to support the protection of sensitive information BOCA RATON, FL, May 16,
![Blog header image insights](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Blog_18Apr22-scaled.jpg)
CMS RADV Final Rule is Here: How to be Proactive
The Increased Scrutiny Presented by the RADV Final Rule Requires Providers to Remain More Proactive with their Health Plans and Collaborate Better Providers and payers
![Press Release header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Press-Release_18Apr22-scaled.jpg)
Omega Healthcare Named “Star Performer” in RCM Operations PEAK Matrix® Assessment 2022
Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022 Marks the fifth year that Omega has been ranked as
![Medicine doctor and stethoscope in hand touching icon medical network connection with modern virtual screen interface, medical technology network concept](https://www.omegahms.com/wp-content/uploads/2022/03/WhatweOffer-scaled.jpg)
Omega Healthcare Completes Acquisition of ApexonHealth and Vasta Global
Omega Healthcare Completes Acquisition of ApexonHealth and Vasta Global Boca Raton, FL, April 13, 2022: Omega Healthcare, a leading technology-enabled healthcare management solutions provider, today
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week-07-19-2024 Pulse Check 2024 Abstracting
07-19-2024 Pulse Check 2024 Abstracting Most have started abstracting 2024 cases by now, just wanted to do a little check to make sure everyone has
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week 07-12-2024 Clear Cell Papillary Renal Cell Ca-do not use your drop-down menu
Scenario: 2024 RIGHT KIDNEY NEPHRECTOMY: -CLEAR-CELL PAPILLARY RENAL CELL CARCINOMA Question: How would you code histology? 8260 Papillary renal cell carcinoma (C64.9) 8312 Renal cell
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week-06-28-2024 No DRE-No Clinical T, a cT BLANK is better than an assumption
06-28-2024 No DRE-No Clinical T, a cT BLANK is better than an assumption We have seen a trend where Urologists are not performing or not
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week- 06-21-2024 Make sure you are recording all treatment -includes treatment done-recommended-refused-contraindicated
Just as important as it is to code the treatment a patient received, you also need to code when a treatment is not given due
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week 06-07-2024 Radiation Treatment Volume GYN Brachytherapy after TAHBSO
Scenario: • Endometrioid Adenocarcinoma pT3b pN0 treated with TAH/BSO + XRT • Phase 1 XRT: 2/10/2024 to 3/13/2024, Whole pelvis XRT IMRT/6x, 180 cGy x
![Tumor Tip header image](https://www.omegahms.com/wp-content/uploads/2022/03/omega_web-headers_Tumor-Tip_18Apr22-scaled.jpg)
Tumor Tip of the Week 05-31-2024 Most Specific vs Distinctly Different
Scenario: 2024 Endometrium, curettage: Endometrioid adenocarcinoma, FIGO GR 1 w/ squamous differentiation. TAH/BSO SLN Dissection: Endometrium – Endometrioid adenocarcinoma (FIGO GR 1), confined to the